RETINAL DEGENERATION

This study tests a new treatment called OpCT-001, made from stem cells, for people with inherited retinal diseases that cause vision loss. About 54 adults will receive a single injection of these cells under the retina. The goal is to see if it is safe and whether it can improve …

This study tests whether dapagliflozin, a drug used for diabetes, can slow the progression of geographic atrophy—an advanced form of dry age-related macular degeneration that causes blind spots. About 70 adults aged 50 and older with this condition will take the drug for 12 month…

This study tests a high-resolution imaging system to see tiny structures in the eye that routine tools cannot detect. Researchers will scan 1,200 people with various eye conditions and healthy volunteers. The goal is to better understand diseases like glaucoma, diabetes, and reti…

This study uses special cameras to take ultra-detailed pictures of the back of the eye in people with retinal diseases like macular degeneration and retinitis pigmentosa. Researchers aim to develop new ways to diagnose and track these conditions by measuring cell density and func…

This study aims to understand how rod and cone cells in the eye work in healthy people and those with retinal diseases like retinitis pigmentosa and Stargardt's disease. Researchers will test how well participants see in the dark using special vision tests and eye exams. Up to 50…

This study collects skin, hair, blood, urine, or saliva samples from people with certain eye diseases (like macular degeneration) and from healthy volunteers. Researchers will turn these samples into stem cells in the lab to study how the diseases develop and to test potential ne…